Mollie H. Wright

Schedule-Dependent Synergy between the Heat Shock Protein 90 Inhibitor 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin and Doxorubicin Restores Apoptosis to p53-Mutant Lymphoma Cell Lines

A. Wiestner, A. Robles, Mollie H. Wright, 2006, Clinical Cancer Research.

HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair

A. Robles, J. Bradsher, Mollie H. Wright, 2008, Molecular Cancer Therapeutics.

Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance.

Y. Pommier, A. Robles, Z. Miao, 2007, Cancer research.

Bisindenoisoquinoline NSC 727357, a DNA intercalator and topoisomerase inhibitor with antitumor activity

Y. Pommier, S. Holbeck, Z. Miao, 2006 .

Bisindenoisoquinoline Bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA Intercalator and Topoisomerase Inhibitor with Antitumor Activity

Y. Pommier, S. Holbeck, Z. Miao, 2006, Molecular Pharmacology.

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

C. D. Salcido, A. Calcagno, S. Ambudkar, 2008, Breast Cancer Research.

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1

Jason I. Herschkowitz, C. Perou, A. Robles, 2008, Molecular Cancer.

Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity

W. Telford, Mollie H. Wright, L. Varticovski, 2008, BMC Cancer.